We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$222M
AUM Growth
+$40.5M
(+22%)
Cap. Flow
+$1.63M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
37.72%
Holding
279
New
87
Increased
52
Reduced
12
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FSL
FREESCALE SEMICONDUCTOR LTD
FSL
|
+$2.14M |
| 2 |
IGTE
IGATE CORPORATION
IGTE
|
+$2.13M |
| 3 |
Globalstar
GSAT
|
+$2.12M |
| 4 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$2.08M |
| 5 |
OCR
OMNICARE INC
OCR
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$3.99M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$2.93M |
| 3 |
ARUN
ARUBA NETWORKS, INC.
ARUN
|
+$2.38M |
| 4 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$2.35M |
| 5 |
CRRC
COURIER CORP
CRRC
|
+$2.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.08% |
| 2 | Financials | 3.98% |
| 3 | Energy | 3.73% |
| 4 | Communication Services | 3.14% |
| 5 | Consumer Staples | 2.98% |
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q2 2015 Portfolio in Review
As of Q2 2015, Telemetry Investments held 279 positions worth $222M, up 22% from $181M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Telemetry Investments's Q2 2015 filing shows 87 new, 52 increased, 12 reduced and 112 closed positions. Its largest new stake was IGATE CORPORATION: 46,055 shares worth $2.2M. The largest sale was SALIX PHARMACEUTICALS LTD DEL, an estimated $3.99M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Financials and Energy.
- Telemetry Investments's largest Q2 2015 buy was IGATE CORPORATION: 46,055 shares worth $2.2M.
- Telemetry Investments added most to FREESCALE SEMICONDUCTOR LTD in Q2 2015, an estimated $2.14M increase.
- Telemetry Investments's biggest Q2 2015 reduction was Orexigen Therapeutics, Inc., cutting an estimated $2.35M.
- Telemetry Investments fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $3.99M.
- Telemetry Investments's ten largest holdings make up 38% of its $222M portfolio in Q2 2015.
- Telemetry Investments opened 87 new positions and closed 112 in Q2 2015.
- Telemetry Investments's portfolio value rose 22% quarter-over-quarter to $222M.
Based on Telemetry Investments's 13F filing for Q2 2015, filed 14 Aug 2015.